Medical Marijuana Inc.’s Marketing Company Joins Medical Cannabis Network

Publishing & Media

Share Tweet

Medical Marijuana Inc.’s Marketing Company Joins Medical Cannabis Network

Medical Marijuana Inc. (OTC PINK: MJNA) announced Apr. 2 that its marketing company HempMedsPX™ has finalized a strategic marketing partnership with Medical Cannabis Network.

Medical Cannabis Network will directly market HempMedsPX™ through its and brands. The online following of these Medical Cannabis Network brands includes more than 6,000 dispensaries, 100,000 opt-in newsletter subscribers, 148,000 “Likes” on Facebook and 35,000 followers on Twitter.

The immediate benefit to Medical Marijuana Inc. is an increase in consumer awareness and an increase in the visibility of the cannabidiol (CBD)-rich hemp oil products that HempMedsPX™ represents.

This is just one of several major announcements recently made by the San Diego holding company.

On Mar. 20, Medical Marijuana announced that it signed a memorandum of understanding to develop a joint venture with LiveWire Ergogenics Inc. (OTCQB: LVVV) under the name of HempWire, LLC.

This is the company’s foray into the functional foods market with immediate distribution through LiveWire's extensive chain of existing convenience store retailers, grocery stores, and pharmacy chain stores.

Medical Marijuana continues to employ a formidable diversified strategy in order to establish a foothold in the burgeoning legal marijuana industry. 

For example, on Jan. 31, Medical Marijuana said that it had entered into an agreement with an unnamed company to sell Medial Marijuana’s anti-aging cream through the unnamed company’s in-home sales force.

According to the release, the first purchase order from the home-based business organization will be $1,072,251 in products that will ship before the end of the first quarter.

This positive news came a few days after Medical Marijuana announced its newly-formed subsidiaries would be providing armored transport services for companies in the cannabis industry.

Marijuana Inc.’s subsidiary, Wellness Managed Services, has gained this capability by purchasing a 50% stake in MPS International.

Cannabis Security Issue

In a written statement, MPS International’s CEO Mike Roberts outlined some specifics about the new armored marijuana transport service.

“Large amounts of product will be moved from grow to wholesaler, warehouse, testing facilities, bakeries, infusion laboratories and finally to retail locations,” Roberts said. “Post transaction, and especially right now with federal regulations prohibiting FDIC insured banks from offering financial services to cannabis industry businesses, large amounts of cash will need to be transported between parties securely as this creates an easy target for predators and competing businesses,” he added.

Potentially Lucrative Opportunity

In the release, Roberts went on to outline the potential opportunity that existed for providing armor transportation for currently legal cannabis businesses.  He pointed out that there are now about 448 dispensaries in Colorado alone, while in California there are an estimated 2,700 dispensaries, co-operatives, wellness clinics, and taxi delivery services. 

“Using an average of one armed security officer working 10 hour shifts, 7 days per week billing at the industry standard of $25/hour armed, 52 weeks per year, annual gross revenue created by just 11 locations is more than $1,000,000 for just static physical security,” Roberts explained.

Once the company establishes this footprint, it says it will evaluate other cannabis markets such as those in Canada.

On Apr. 4, MJNA share price closed at 28 cents, down 1 cent from its closing price of the 29 cents the previous day.

Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser:


Primco Management First Medical-Marijuana Collective to Serve Over 1,500 Patients

Meanwhile, Primco Management Inc. (OTCQB: PMCM) has begun construction on Suzie Q's, its first medical-marijuana collective,  in the final phase of the Washington State Liquor Board Tier I Producer/Processor licensing process.

Once completed, the new upgraded and fully compliant facility will pave the way for the issuance of the Producer/Processor License.

It was Mar. 19 when Primco first announced it had acquired Seattle-based Suzie Q's, a medical marijuana collective fully licensed by the City of Seattle.

Suzie Q's has been in operation for more than four years and serves over 1,500 patients. The agreement calls for the purchase of 100% of the assets of the co-op as well as the purchase and transfer of a Tier I Production License granted by the Washington State Liquor Board.

“The acquisition of Suzie Q's, one of the first fully licensed facilities in Seattle, gives us a base of operations which tie in perfectly with our plans in nearby Vancouver,” stated Primco’s CEO David Michery.

“Once we complete the acquisition of Suzie Q's, we believe that we can significantly increase the current revenue stream over the next few months. Primco is in the early stages of establishing a massive marketing campaign to launch our new brand. By delivering the highest quality medicine at competitive levels, the Suzie Q's brand will grow to become one of the most trusted names in medical cannabis,” he added. 

Moving Forward

This is just the latest move by Primco to enlarge its footprint in the medical marijuana industry.

The company entered into a joint venture with British Columbia-based CanMed Ventures on Feb. 24 to build and operate a 30,000-square-foot cultivation facility for the production of medical marijuana.

Primco said it expects to be fully licensed within 6 months and generating first-year revenues exceeding $20 million.

This is just Primco Management’s latest move to develop various properties in order to lease them to companies growing or selling legal marijuana.

Also Acquiring Property in Los Angeles

On Feb. 12 the company said it also planned to initially acquire property in the greater Los Angeles area with subsequent plans to extend its operations to Western states where medical marijuana is permitted by state law. The leased facilities will meet all zoning and licensing requirements for the ongoing, legal dispensing of medical cannabis. Primco will not engage in the cultivation or sale of medical cannabis or any of its byproducts.

On Apr. 4, PMCM’s share price closed at 0.0051 cents, up 0.0051 cents, from its close of 0.005 cents the previous day.  

Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser:


Tranzbyte Corp. Launches E-zine Reporting Marijuana News for Growers and Consumers

In other news, Tranzbyte Corp. (OTCPINK: ERBB) on Apr. 3 launched American GreenZine, an online publication it’s designed to report on the legal-marijuana industry, from the grower and consumer’s perceptive.

According to the Tempe, Ariz.-based company the new online magazine will use real-time web activity of topical influencers to surface the best content on any subject. The American GreenZine publication is scheduled to begin operating Fri., Apr. 4 at 8:20am EDT.

“With every passing day more news and articles come out about this industry, but they are located in 1000 or more different places, and many of the stories are musings by pundits who may know much or nothing at all about the industry. By aggregating and organizing the information, we provide a portal through which people can get all the news they want and filter it on their own,” said David Gwyther, Tranzbyte's president.

This is just the latest chapter in Tranzbyte’s many marijuana-related business ventures. 

 On Mar. 21, the company announced that it signed a Letter of Intent to form a strategic partnership with Abattis (OTC Pink: ATTBF).

Under terms of the agreement, the companies will sell and market or otherwise license one another's products in their respective regions. Once the arrangement is completed, Tranzbyte will have access to Abattis’ expanding suite of bio-ceutical grow products found in the Biocube Green Grow Systems for cultivation (LED's, Nutrients - Natures Juice).

In addition, Abattis owns proprietary flash freeze extraction technology, which produces high-grade cannabis and other botanical extracts. Conversely, Abattis will have the Canadian rights to distribute ZaZZZ™ and will pair Tranzbyte's Jurassic O2 water systems with its Biocube Green Grow Systems sales efforts in the US.

On Apr. 4, ERBB’s share price closed at 7 cents, down 1 cent from closing price of the previous day of 8 cents, on volume of 85.4 million shares.

Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser:


Growlife Inc.’s Extends Due Diligence for Joint Venture to End of April

Finally, Growlife Inc. (OTCBB: PHOT) announced that it has moved the date for completion of its due diligence and closing the transaction on its joint venture with CANX USA LLC and RXNB Inc. to Apr. 30, 2014.

No specific reason was given as to why the extension was necessary, or what part of the due diligence hadn’t been completed.

Distribute Proprietary Technologies

Under the agreement, GrowLife will sell and distribute RXNB proprietary technologies globally, and share profits related to technology licensing, subject to the approval of the GrowLife Board of Directors. GrowLife currently has a 45% ownership interest in OGI, with conditions under which it can gain majority interest.

RXNB is an investment company with holdings in drug formulation, manufacturing, and distribution. The company represents a recent roll-up of several independent companies in the pharmaceutical and nutraceutical market. RXNB has numerous pending patents in the field of THC research and development.

Annual Report

Growlife recently released its annual report and financial results for the fiscal year ending December 31, 2013.

In a press release, the Woodland Hills, Calif. holding company that supplies equipment for legal marijuana growers outlined some of its results:

“GrowLife revenues for 2013 revenue from sales increased to $4,858,976 from $1,450,745, an increase of $3,408,231 or 235% compared against audited revenues in 2012. For the quarter ended December 31, 2013, Q4, revenue was $1,912,311, an increase of $1,237,691, an 183% increase compared to the $674,620 in revenues recorded for the same period in 2012,” the release said.

But Growlife’s 10-K form filed with the Security and Exchange Commission gave more details including its net loss:

Net Loss

“The net loss for the year ended December 31, 2013 was $21,380,138 with the same period in fiscal 2012 generating a loss of $2,186,304. As noted above in ‘Other Expenses’, a significant portion of the company's net loss for fiscal year 2013 is related to non-cash expenses.”

On Apr. 4, PHOT shares closed at 57 cents down 2 cents from its closing price of 59 cents the previous day, on volume of 19.9 million shares.  

Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser:


ABOUT US: issues momentum alerts on stocks that can provide gains to day traders. provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:


Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.